- Home
- LPTH vs NMRA Comparison
LPTH vs NMRA Comparison
Compare LPTH & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- NMRA
- Stock Information
- Founded
- LPTH 1985
- NMRA 2019
- Country
- LPTH United States
- NMRA United States
- Employees
- LPTH N/A
- NMRA N/A
- Industry
- LPTH Semiconductors
- NMRA
- Sector
- LPTH Technology
- NMRA
- Exchange
- LPTH Nasdaq
- NMRA Nasdaq
- Market Cap
- LPTH 128.3M
- NMRA 121.0M
- IPO Year
- LPTH 1996
- NMRA 2023
- Fundamental
- Price
- LPTH $2.93
- NMRA $0.79
- Analyst Decision
- LPTH Strong Buy
- NMRA Buy
- Analyst Count
- LPTH 3
- NMRA 8
- Target Price
- LPTH $4.67
- NMRA $9.29
- AVG Volume (30 Days)
- LPTH 183.9K
- NMRA 872.1K
- Earning Date
- LPTH 05-15-2025
- NMRA 08-05-2025
- Dividend Yield
- LPTH N/A
- NMRA N/A
- EPS Growth
- LPTH N/A
- NMRA N/A
- EPS
- LPTH N/A
- NMRA N/A
- Revenue
- LPTH $33,626,969.00
- NMRA N/A
- Revenue This Year
- LPTH $19.58
- NMRA N/A
- Revenue Next Year
- LPTH $44.50
- NMRA N/A
- P/E Ratio
- LPTH N/A
- NMRA N/A
- Revenue Growth
- LPTH 2.59
- NMRA N/A
- 52 Week Low
- LPTH $1.04
- NMRA $0.61
- 52 Week High
- LPTH $4.42
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- LPTH 55.46
- NMRA 45.74
- Support Level
- LPTH $2.90
- NMRA $0.81
- Resistance Level
- LPTH $3.25
- NMRA $1.34
- Average True Range (ATR)
- LPTH 0.18
- NMRA 0.10
- MACD
- LPTH -0.02
- NMRA -0.01
- Stochastic Oscillator
- LPTH 25.72
- NMRA 12.55
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.